Literature DB >> 14613673

Ethics of research and the pregnant patient.

Frank A Chervenak1, Laurence B McCullough.   

Abstract

In this chapter, we address ethical issues in research involving fetuses and pregnant women, with particular attention to the emerging issue of gene-transfer research. Ethical analyses and arguments are based on the concept of the fetus as a patient. The implications of this concept for the ethics of fetal research are identified. The discussion of gene-transfer research extends those implications to address issues concerning informed consent, assessment of potential fetal and neonatal morbidity in study design, prenatal diagnosis after gene transfer, selection criteria based on abortion preference, science by press conference, germline risks, and public oversight.

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  2003        PMID: 14613673

Source DB:  PubMed          Journal:  Curr Womens Health Rep        ISSN: 1534-5874


  3 in total

1.  Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.

Authors:  Annemarie Unger; Reinhold Jagsch; Hendree Jones; Amelia Arria; Harald Leitich; Klaudia Rohrmeister; Constantin Aschauer; Berndadette Winklbaur; Andjela Bäwert; Gabriele Fischer
Journal:  Addiction       Date:  2011-05-12       Impact factor: 6.526

Review 2.  The ethical issues regarding consent to clinical trials with pre-term or sick neonates: a systematic review (framework synthesis) of the analytical (theoretical/philosophical) research.

Authors:  Christopher Megone; Eleanor Wilman; Sandy Oliver; Lelia Duley; Gill Gyte; Judy Wright
Journal:  Trials       Date:  2016-09-09       Impact factor: 2.279

Review 3.  The moral imperative to approve pregnant women's participation in randomized clinical trials for pregnancy and newborn complications.

Authors:  Dan Kabonge Kaye
Journal:  Philos Ethics Humanit Med       Date:  2019-09-06       Impact factor: 2.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.